Production (Stage)
Integrated Biopharma, Inc.
INBP
$0.29
-$0.0135-4.45%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.96M | 2.46M | 2.27M | 1.68M | 2.02M |
| Total Receivables | 5.08M | 4.23M | 4.39M | 4.67M | 4.72M |
| Inventory | 10.08M | 11.07M | 11.22M | 11.24M | 11.17M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 428.00K | 398.00K | 432.00K | 286.00K | 353.00K |
| Total Current Assets | 18.55M | 18.15M | 18.31M | 17.88M | 18.26M |
|
|
|||||
| Total Current Assets | 18.55M | 18.15M | 18.31M | 17.88M | 18.26M |
| Net Property, Plant & Equipment | 2.95M | 3.09M | 3.41M | 3.68M | 3.91M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.16M | 4.41M | 4.46M | 4.66M | 4.77M |
| Total Assets | 25.66M | 25.66M | 26.18M | 26.21M | 26.94M |
|
|
|||||
| Total Accounts Payable | 2.50M | 2.81M | 2.76M | 2.51M | 3.67M |
| Total Accrued Expenses | 1.64M | 1.80M | 2.31M | 2.66M | 2.32M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 844.00K | 964.00K | 954.00K | 952.00K | 953.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 4.98M | 5.58M | 6.03M | 6.12M | 6.95M |
|
|
|||||
| Total Current Liabilities | 4.98M | 5.58M | 6.03M | 6.12M | 6.95M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 292.00K | 359.00K | 604.00K | 846.00K | 1.09M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.27M | 5.93M | 6.63M | 6.97M | 8.03M |
|
|
|||||
| Common Stock & APIC | 51.72M | 51.68M | 51.62M | 51.56M | 51.51M |
| Retained Earnings | -31.24M | -31.85M | -31.97M | -32.23M | -32.50M |
| Treasury Stock & Other | -99.00K | -99.00K | -99.00K | -99.00K | -99.00K |
| Total Common Equity | 20.38M | 19.73M | 19.55M | 19.24M | 18.91M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.38M | 19.73M | 19.55M | 19.24M | 18.91M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.38M | 19.73M | 19.55M | 19.24M | 18.91M |
|
|
|||||